246 related articles for article (PubMed ID: 17573238)
21. The two sides of associative plasticity in writer's cramp.
Weise D; Schramm A; Stefan K; Wolters A; Reiners K; Naumann M; Classen J
Brain; 2006 Oct; 129(Pt 10):2709-21. PubMed ID: 16921180
[TBL] [Abstract][Full Text] [Related]
22. Gray matter atrophy in multiple sclerosis: a longitudinal study.
Fisher E; Lee JC; Nakamura K; Rudick RA
Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
[TBL] [Abstract][Full Text] [Related]
23. Nerve excitability changes in critical illness polyneuropathy.
Z'Graggen WJ; Lin CS; Howard RS; Beale RJ; Bostock H
Brain; 2006 Sep; 129(Pt 9):2461-70. PubMed ID: 16901913
[TBL] [Abstract][Full Text] [Related]
24. Effects of experimental focal compression on excitability of human median motor axons.
Ikemoto T; Tani T; Taniguchi S; Ikeuchi M; Kimura J
Clin Neurophysiol; 2009 Feb; 120(2):342-7. PubMed ID: 19101203
[TBL] [Abstract][Full Text] [Related]
25. The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study.
Abo-Krysha N; Rashed L
Mult Scler; 2008 Jun; 14(5):602-8. PubMed ID: 18408021
[TBL] [Abstract][Full Text] [Related]
26. Altered supernormality in multiple sclerosis peripheral nerve.
Eisen A; Paty D; Hoirch M
Muscle Nerve; 1982; 5(5):411-4. PubMed ID: 6289099
[TBL] [Abstract][Full Text] [Related]
27. Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis.
Pueyo V; Martin J; Fernandez J; Almarcegui C; Ara J; Egea C; Pablo L; Honrubia F
Mult Scler; 2008 Jun; 14(5):609-14. PubMed ID: 18424482
[TBL] [Abstract][Full Text] [Related]
28. The effect of temporal dispersion on compound action potential area in human peripheral nerve.
Olney RK; Budingen HJ; Miller RG
Muscle Nerve; 1987 Oct; 10(8):728-33. PubMed ID: 3683446
[TBL] [Abstract][Full Text] [Related]
29. Velocity recovery cycles of human muscle action potentials and their sensitivity to ischemia.
Z'graggen WJ; Bostock H
Muscle Nerve; 2009 May; 39(5):616-26. PubMed ID: 19229874
[TBL] [Abstract][Full Text] [Related]
30. Normal maximal and minimal motor nerve conduction velocities in adults determined by a collision method.
Arasaki K; Iijima M; Nakanishi T
Muscle Nerve; 1991 Jul; 14(7):647-53. PubMed ID: 1922171
[TBL] [Abstract][Full Text] [Related]
31. Natalizumab restores evoked potential abnormalities in patients with relapsing-remitting multiple sclerosis.
Meuth SG; Bittner S; Seiler C; Göbel K; Wiendl H
Mult Scler; 2011 Feb; 17(2):198-203. PubMed ID: 21135021
[TBL] [Abstract][Full Text] [Related]
32. Transcranial electric stimulation for intraoperative motor evoked potential monitoring: Stimulation parameters and electrode montages.
Szelényi A; Kothbauer KF; Deletis V
Clin Neurophysiol; 2007 Jul; 118(7):1586-95. PubMed ID: 17507288
[TBL] [Abstract][Full Text] [Related]
33. Differences in membrane properties of axonal and demyelinating Guillain-Barré syndromes.
Kuwabara S; Ogawara K; Sung JY; Mori M; Kanai K; Hattori T; Yuki N; Lin CS; Burke D; Bostock H
Ann Neurol; 2002 Aug; 52(2):180-7. PubMed ID: 12210788
[TBL] [Abstract][Full Text] [Related]
34. Increased nodal persistent Na+ currents in human neuropathy and motor neuron disease estimated by latent addition.
Tamura N; Kuwabara S; Misawa S; Kanai K; Nakata M; Sawai S; Hattori T
Clin Neurophysiol; 2006 Nov; 117(11):2451-8. PubMed ID: 16996798
[TBL] [Abstract][Full Text] [Related]
35. [Sensitivity of motor evoked potentials in detecting cortico-spinal lesions in patients with multiple sclerosis].
Gómez-Fernández L; Minou-Báez M; Cabrera-Gómez JA
Rev Neurol; 1999 Feb 16-28; 28(4):357-60. PubMed ID: 10714312
[TBL] [Abstract][Full Text] [Related]
36. Peripheral sensory and motor abnormalities in patients with multiple sclerosis.
Anlar O; Tombul T; Kisli M
Electromyogr Clin Neurophysiol; 2003 Sep; 43(6):349-51. PubMed ID: 14535047
[TBL] [Abstract][Full Text] [Related]
37. Abnormalities in brain synchronization are correlated with cognitive impairment in multiple sclerosis.
Arrondo G; Alegre M; Sepulcre J; Iriarte J; Artieda J; Villoslada P
Mult Scler; 2009 Apr; 15(4):509-16. PubMed ID: 19282416
[TBL] [Abstract][Full Text] [Related]
38. Changes in measures of motor axon excitability with age.
Jankelowitz SK; McNulty PA; Burke D
Clin Neurophysiol; 2007 Jun; 118(6):1397-404. PubMed ID: 17452010
[TBL] [Abstract][Full Text] [Related]
39. The transition from relapsing-remitting MS to irreversible disability: clinical evaluation.
Trojano M; Paolicelli D; Bellacosa A; Cataldo S
Neurol Sci; 2003 Dec; 24 Suppl 5():S268-70. PubMed ID: 14652786
[TBL] [Abstract][Full Text] [Related]
40. Intracortical excitability in patients with relapsing-remitting and secondary progressive multiple sclerosis.
Conte A; Lenzi D; Frasca V; Gilio F; Giacomelli E; Gabriele M; Bettolo CM; Iacovelli E; Pantano P; Pozzilli C; Inghilleri M
J Neurol; 2009 Jun; 256(6):933-8. PubMed ID: 19252788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
